ArticleFrontiers in genetics2022

Integrated pan-cancer analysis of CSMD2 as a potential prognostic, diagnostic, and immune biomarker.

Huiyun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.